The Division of Research encompasses multiple initiatives as follows:

  1. Basic immunology research focusing on the biology of graft-versus-host disease (GVHD), a common, potentially fatal complication of stem cell transplantation. Our scientists were responsible for some of the breakthrough discoveries in GVHD over the past 25 years, as well as studies of the immunological repertoire post stem cell transplantation. In addition, our scientists showed the benefit of modifying donor T-cells (TH-2 amplification) to reduce incidence of GVHD and improve anti tumor effect. The immunology research lab at HUMC has ongoing collaboration with the National Institute of Health, the Dana Farber Cancer Center in Boston, and the Multiple Myeloma Research Foundation.
  2. Genetics initiative: our Tissue Repository has now collected thousands of samples from over 3,500 patients since inception. Ongoing research has focused on the characterization of biomarkers, particularly in mantle cell lymphoma and Hodgkin lymphoma and other tumors through external collaborations.
  3. Ex-vivo primary culture for expansion of tumor cells. This program, particularly in collaboration with the Stevens Institute, has established the ability to grow multiple myeloma cells in a micro device that might offer an opportunity for drug testing, as well as further understanding the biology of multiple myeloma cells.

Our clinical research team is the largest in New Jersey, with over 65 dedicated staff for adult oncology research only. We have over 300 ongoing clinical trials, including a dedicated Phase I unit (with multiple first in-human ongoing studies) to provide our patients with crucial novel options in a rapidly changing environment with thousands of novel therapies on the horizon.

The Research Division Team

RCCA0131

MARTIN GUTIERREZ, MD
Director, Drug Discovery/Phase 1 Unit, Medical Oncologist, Thoracic and Gastrointestinal Oncology

READ BIO

RCCA0131

ROBERT KORNGOLD, PH.D.
Chief, Research

READ BIO

RCCA0131

ERNEST W. RICHARDS, PHD, FACN
Director of Research

READ BIO

RCCA0131

K. STEPHEN SUH, PH.D.
Director, Genomics and Biomarkers Program

READ BIO

Director of Research

Ernest Richards, PhD, FACN

Research Management

Urszula Bednarz, Supervisor Data Management
Grace Kranwinkel, Supervisor Regulatory and Quality Control
Alex Schramm, Manager Oncology Research Finance

Advanced Practice Nurse/Nurse Navigator

Beth Boseski, APN, RN
Jayshree Shaw
Samantha Siegel

Research Nurses

Nursing and Research Education
Laura Long, MSN, RN, CCRP

Bone Marrow Transplant
Jacqueline Callahan, MPH, RN, OCN
Andrea Ortega, BS, RN
Marifel Vendivil, BSN, RN, OCN, CCRC

Leukemia
Michelle Borza, MSN, MHA, RN
Marlo Kemp, MS, RN
Gillian Velardi, BSN, RN

Lymphoma
Sabrina Kdiry, BSN, RN, CCRP
Elizabeth McCarthy, BSN, RN
Kara Yannotti, MMH, RN, CCRP

Multiple Myeloma
Palka Anand, BSN, RN, CCRP
Kristin Ivanovski, BSN, RN, CCRP
Laura McBride, BSN, RN, OCN, CCRP
Judy Smith

Phase I
Allison Abate, MSN, RN, OCN
Leah Capadonna, BSN, RN, OCN
Laura Esposito, AS, RN, CCRP
Lauren Finaldi
Morgan Finlay, BS, RN
Sora Limor, MSN, RN, CCRP
Luzviminda Dorsett, APN-BC, MSN, RN, OCN
Luis Serna, RN, MSN, FNPc

Solid Tumors
Danielle Blair, BSN, RN, OCN, CCRP
Lori Cappello, BSN, RN, CCRP
Aretha DiSalvo, BSN, RN, OCN, CCRP
Seana Krauss, BSN, RN
Jessica Marchisotto, BSN, RN

Oncology Nurse Navigator

Joanna Mohney, BSN, RN, OCN

Social Work Support Services

Andrea Nudelman, L.C.S.W, OSW-C

Call for an appointment

Hackensack: 551-996-5900
Palisades: 201-464-0008

To reach the extension of Dr. Gutierrez please dial ext. 5863.

Innovations in the Treatment of Amyloidosis Suzanne Lentzsch M.D., PhD from Hackensack Meridian Health on Vimeo.